These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 26735580)
1. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology. Liu Y; Lu Z; Xu R; Ke Y Oncotarget; 2016 Feb; 7(5):5852-64. PubMed ID: 26735580 [TBL] [Abstract][Full Text] [Related]
2. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma. Peter M; Stransky N; Couturier J; Hupé P; Barillot E; de Cremoux P; Cottu P; Radvanyi F; Sastre-Garau X J Pathol; 2010 Jul; 221(3):320-30. PubMed ID: 20527025 [TBL] [Abstract][Full Text] [Related]
3. Loss of gene function as a consequence of human papillomavirus DNA integration. Schmitz M; Driesch C; Beer-Grondke K; Jansen L; Runnebaum IB; Dürst M Int J Cancer; 2012 Sep; 131(5):E593-602. PubMed ID: 22262398 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of HPV physical status and integration sites in cervical cancer. Nambaru L; Meenakumari B; Swaminathan R; Rajkumar T Asian Pac J Cancer Prev; 2009; 10(3):355-60. PubMed ID: 19640172 [TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Iwasawa A; Nieminen P; Lehtinen M; Paavonen J Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095 [TBL] [Abstract][Full Text] [Related]
6. Mate pair sequencing of oropharyngeal squamous cell carcinomas reveals that HPV integration occurs much less frequently than in cervical cancer. Gao G; Johnson SH; Kasperbauer JL; Eckloff BW; Tombers NM; Vasmatzis G; Smith DI J Clin Virol; 2014 Mar; 59(3):195-200. PubMed ID: 24440282 [TBL] [Abstract][Full Text] [Related]
7. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Thorland EC; Myers SL; Gostout BS; Smith DI Oncogene; 2003 Feb; 22(8):1225-37. PubMed ID: 12606949 [TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Thorland EC; Myers SL; Persing DH; Sarkar G; McGovern RM; Gostout BS; Smith DI Cancer Res; 2000 Nov; 60(21):5916-21. PubMed ID: 11085503 [TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: review of the literature of human papillomavirus detection in these carcinomas. Ogura K; Ishi K; Matsumoto T; Kina K; Nojima M; Suda K Pathol Int; 2006 Jun; 56(6):301-8. PubMed ID: 16704493 [TBL] [Abstract][Full Text] [Related]
11. Prevalence, distribution, and viral burden of all 15 high-risk human papillomavirus types in adenosquamous carcinoma of the uterine cervix: a multiplex real-time polymerase chain reaction-based study. Quddus MR; Manna P; Sung CJ; Kerley S; Steinhoff MM; Lawrence WD Hum Pathol; 2014 Feb; 45(2):303-9. PubMed ID: 24355194 [TBL] [Abstract][Full Text] [Related]
12. Determination of integrated HPV58 sequences in cervical lesions. Li H; Zhang R; Cai Y; Li Y; Cheng X; Zhu B; Yang Y; Xiang Y Int J Gynecol Cancer; 2012 Sep; 22(7):1234-7. PubMed ID: 22801029 [TBL] [Abstract][Full Text] [Related]
13. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis. Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645 [TBL] [Abstract][Full Text] [Related]
14. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers. Szarka K; Veress G; Juhász A; Kónya J; Sápy T; Soós G; Hernádi Z; Gergely L Anticancer Res; 2000; 20(3B):2161-7. PubMed ID: 10928171 [TBL] [Abstract][Full Text] [Related]
15. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques. Ziegert C; Wentzensen N; Vinokurova S; Kisseljov F; Einenkel J; Hoeckel M; von Knebel Doeberitz M Oncogene; 2003 Jun; 22(25):3977-84. PubMed ID: 12813471 [TBL] [Abstract][Full Text] [Related]
16. Genome-wide profiling of human papillomavirus DNA integration in liquid-based cytology specimens from a Gabonese female population using HPV capture technology. Nkili-Meyong AA; Moussavou-Boundzanga P; Labouba I; Koumakpayi IH; Jeannot E; Descorps-Declère S; Sastre-Garau X; Leroy EM; Belembaogo E; Berthet N Sci Rep; 2019 Feb; 9(1):1504. PubMed ID: 30728408 [TBL] [Abstract][Full Text] [Related]
17. Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines. Koopman LA; Szuhai K; van Eendenburg JD; Bezrookove V; Kenter GG; Schuuring E; Tanke H; Fleuren GJ Cancer Res; 1999 Nov; 59(21):5615-24. PubMed ID: 10554043 [TBL] [Abstract][Full Text] [Related]
18. Situation of HPV16 E2 gene status during radiotherapy treatment of cervical carcinoma. Kahla S; Kochbati L; Maalej M; Oueslati R Asian Pac J Cancer Prev; 2014; 15(6):2869-73. PubMed ID: 24761916 [TBL] [Abstract][Full Text] [Related]
19. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV. Hopman AH; Kamps MA; Smedts F; Speel EJ; Herrington CS; Ramaekers FC Int J Cancer; 2005 Jun; 115(3):419-28. PubMed ID: 15688369 [TBL] [Abstract][Full Text] [Related]
20. Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines. Hatano T; Sano D; Takahashi H; Hyakusoku H; Isono Y; Shimada S; Sawakuma K; Takada K; Oikawa R; Watanabe Y; Yamamoto H; Itoh F; Myers JN; Oridate N Int J Cancer; 2017 Apr; 140(7):1571-1580. PubMed ID: 28006857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]